Ranbaxy Reports Record Quarterly Loss After U.S. Settlement

Ranbaxy Reports Record Quarterly Loss After U.S. Settlement

Scott Eells/Bloomberg

A 40 mg tablet of Ranbaxy Laboratories Ltd.'s Storvas, a generic version of Lipitor.